237 related articles for article (PubMed ID: 23497521)
1. Blood brain barrier breakdown as the starting point of cerebral small vessel disease? - New insights from a rat model.
Schreiber S; Bueche CZ; Garz C; Braun H
Exp Transl Stroke Med; 2013 Mar; 5(1):4. PubMed ID: 23497521
[TBL] [Abstract][Full Text] [Related]
2. Stases are associated with blood-brain barrier damage and a restricted activation of coagulation in SHRSP.
Braun H; Bueche CZ; Garz C; Oldag A; Heinze HJ; Goertler M; Reymann KG; Schreiber S
J Neurol Sci; 2012 Nov; 322(1-2):71-6. PubMed ID: 22831765
[TBL] [Abstract][Full Text] [Related]
3. NAC changes the course of cerebral small vessel disease in SHRSP and reveals new insights for the meaning of stases - a randomized controlled study.
Bueche CZ; Garz C; Kropf S; Bittner D; Li W; Goertler M; Heinze HJ; Reymann K; Braun H; Schreiber S
Exp Transl Stroke Med; 2013; 5():5. PubMed ID: 23587288
[TBL] [Abstract][Full Text] [Related]
4. Early microvascular dysfunction in cerebral small vessel disease is not detectable on 3.0 Tesla magnetic resonance imaging: a longitudinal study in spontaneously hypertensive stroke-prone rats.
Mencl S; Garz C; Niklass S; Braun H; Göb E; Homola G; Heinze HJ; Reymann KG; Kleinschnitz C; Schreiber S
Exp Transl Stroke Med; 2013; 5():8. PubMed ID: 23800299
[TBL] [Abstract][Full Text] [Related]
5. The pathologic cascade of cerebrovascular lesions in SHRSP: is erythrocyte accumulation an early phase?
Schreiber S; Bueche CZ; Garz C; Kropf S; Angenstein F; Goldschmidt J; Neumann J; Heinze HJ; Goertler M; Reymann KG; Braun H
J Cereb Blood Flow Metab; 2012 Feb; 32(2):278-90. PubMed ID: 21878945
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the Neuroimaging and Histopathological Correlates of Cerebral Small Vessel Disease in Spontaneously Hypertensive Stroke-Prone Rats.
Hannawi Y; Caceres E; Ewees MG; Powell KA; Bratasz A; Schwab JM; Rink CL; Zweier JL
Front Neurol; 2021; 12():740298. PubMed ID: 34917012
[No Abstract] [Full Text] [Related]
7. Impact of N-Acetylcysteine on cerebral amyloid-β plaques and kidney damage in spontaneously hypertensive stroke-prone rats.
Bueche CZ; Garz C; Stanaszek L; Niklass S; Kropf S; Bittner D; Härtig W; Reymann KG; Heinze HJ; Carare RO; Schreiber S
J Alzheimers Dis; 2014; 42 Suppl 3():S305-13. PubMed ID: 24898644
[TBL] [Abstract][Full Text] [Related]
8. Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats.
Schreiber S; Drukarch B; Garz C; Niklass S; Stanaszek L; Kropf S; Bueche C; Held F; Vielhaber S; Attems J; Reymann KG; Heinze HJ; Carare RO; Wilhelmus MM
J Alzheimers Dis; 2014; 42 Suppl 3():S205-15. PubMed ID: 24825568
[TBL] [Abstract][Full Text] [Related]
9. Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets.
Gao Y; Li D; Lin J; Thomas AM; Miao J; Chen D; Li S; Chu C
Front Aging Neurosci; 2022; 14():961661. PubMed ID: 36034144
[TBL] [Abstract][Full Text] [Related]
10. Kidney pathology precedes and predicts the pathological cascade of cerebrovascular lesions in stroke prone rats.
Schreiber S; Bueche CZ; Garz C; Kropf S; Kuester D; Amann K; Heinze HJ; Goertler M; Reymann KG; Braun H
PLoS One; 2011; 6(10):e26287. PubMed ID: 22031827
[TBL] [Abstract][Full Text] [Related]
11. A novel rat model of cerebral small vessel disease based on vascular risk factors of hypertension, aging, and cerebral hypoperfusion.
Meng P; Liu T; Zhong Z; Fang R; Qiu F; Luo Y; Yang K; Cai H; Mei Z; Zhang X; Ge J
Hypertens Res; 2024 Jun; ():. PubMed ID: 38872026
[TBL] [Abstract][Full Text] [Related]
12. Cerebral Small Vessel Disease.
Li Q; Yang Y; Reis C; Tao T; Li W; Li X; Zhang JH
Cell Transplant; 2018 Dec; 27(12):1711-1722. PubMed ID: 30251566
[TBL] [Abstract][Full Text] [Related]
13. Advances in the Role of Endothelial Cells in Cerebral Small Vessel Disease.
Bai T; Yu S; Feng J
Front Neurol; 2022; 13():861714. PubMed ID: 35481273
[TBL] [Abstract][Full Text] [Related]
14. Vascular basement membrane alterations and β-amyloid accumulations in an animal model of cerebral small vessel disease.
Held F; Morris AWJ; Pirici D; Niklass S; Sharp MMG; Garz C; Assmann A; Heinze HJ; Schreiber F; Carare RO; Schreiber S
Clin Sci (Lond); 2017 May; 131(10):1001-1013. PubMed ID: 28348005
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous white matter lesion in brain of stroke-prone renovascular hypertensive rats: a study from MRI, pathology and behavior.
Fan Y; Lan L; Zheng L; Ji X; Lin J; Zeng J; Huang R; Sun J
Metab Brain Dis; 2015 Dec; 30(6):1479-86. PubMed ID: 26387009
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier pathology in cerebral small vessel disease.
Jia R; Solé-Guardia G; Kiliaan AJ
Neural Regen Res; 2024 Jun; 19(6):1233-1240. PubMed ID: 37905869
[TBL] [Abstract][Full Text] [Related]
17. Cerebral microangiopathy in stroke-prone spontaneously hypertensive rats. An immunohistochemical and ultrastructural study.
Fredriksson K; Nordborg C; Kalimo H; Olsson Y; Johansson BB
Acta Neuropathol; 1988; 75(3):241-52. PubMed ID: 3348082
[TBL] [Abstract][Full Text] [Related]
18. Alterations of lymphocyte count and platelet volume precede cerebrovascular lesions in stroke-prone spontaneously hypertensive rats.
Nishinaka T; Yamazaki Y; Niwa A; Wake H; Mori S; Yoshino T; Nishibori M; Takahashi H
Biomarkers; 2020 May; 25(3):305-313. PubMed ID: 32285702
[No Abstract] [Full Text] [Related]
19. Cerebral Perfusion Characteristics and Dynamic Brain Structural Changes in Stroke-Prone Renovascular Hypertensive Rats: A Preclinical Model for Cerebral Small Vessel Disease.
Xu X; Xiao C; Yi M; Yang J; Liao M; Zhou K; Hu L; Ouyang F; Lan L; Fan Y
Transl Stroke Res; 2024 Mar; ():. PubMed ID: 38443727
[TBL] [Abstract][Full Text] [Related]
20. The association between hypertensive arteriopathy and cerebral amyloid angiopathy in spontaneously hypertensive stroke-prone rats.
Jandke S; Garz C; Schwanke D; Sendtner M; Heinze HJ; Carare RO; Schreiber S
Brain Pathol; 2018 Nov; 28(6):844-859. PubMed ID: 30062722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
